| 600064 | 南京高科 | 3.000 | - | 8.09 | 0.50 | | --- | --- | --- | --- | --- | --- | | 301025 | 读客文化 | 0.300 | - | 11.11 | -0.09 | | 873806 | 云星宇 | 1.000 | - | 15.98 | -0.37 | | 002973 | 侨银股份 | 1.000 | - | 13.67 | -0.44 | | 600072 | 中船科技 | 0.300 | - | 12.78 | -1.77 | | 300043 | 星辉娱乐 | 0.100 | - | 4.61 | -1.91 | | 000655 | 金岭矿业 | 1.100 | - | 8.57 | -6.75 | 上市公司目前进入分红实施季。证券时报·数据宝统计，以股权登记日为基准，今日24家公司分配方案 将要实施。 统计显示，2024年度推出分配方案的公司合计有3679家。在监管层大力提倡现金分红的背景下，上市公 司现金分红更加积极，2024年度分配方案中含有现金分红的有3674家，累计派现金额1.64万亿元。2024 ...

证券代码：603325 证券简称：博隆技术 公告编号：2025-019 上海博隆装备技术股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 公司不存在首发战略配售股份 ? 每股分配比例，每股转增比例 A 股每股现金红利0.75元（含税） 每股转增股份0.20股 ? 相关日期 新增无限售条件 现金红利 股份类别 股权登记日 最后交易日 除权（息）日 流通股份上市日 发放日 Ａ股 2025/7/22 － 2025/7/23 2025/7/23 2025/7/23 ? 差异化分红送转：否 一、 通过分配、转增股本方案的股东大会届次和日期 本次利润分配及转增股本方案经上海博隆装备技术股份有限公司（以下简称 公司或本公司）2025 年 5 月 30 日的2024年年度股东大会审议通过。 二、 分配、转增股本方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称中国结算上海分公司）登记在册的本公司全体股东。 本次利润分配及转增股本以方案实施前的公司总股本66,670 ...

证券代码：603325 证券简称：博隆技术 公告编号：2025-019 上海博隆装备技术股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： A 股每股现金红利0.75元（含税） 本次利润分配及转增股本方案经上海博隆装备技术股份有限公司（以下简称 公司或本公司）2025 年 5 月 30 日的2024年年度股东大会审议通过。 二、分配、转增股本方案 1. 发放年度：2024年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称中国结算上海分公司）登记在册的本公司全体股东。 1 每股转增股份0.20股 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 新增无限售条件 | 现金红利 | | --- | --- | --- | --- | --- | --- | | | | | | 流通股份上市日 | 发放日 | | Ａ股 | 2025/7/22 | － | 2025/7/23 | 20 ...

公司7月11日在交易所互动平台披露，截至最新（7月10日）股东户数为6625户，较上期（6月30日）增 加95户，环比增长1.45%。这是该股股东户数连续第2期增长，也就是说筹码呈持续分散趋势。 公司发布的一季报数据显示，一季度公司共实现营业收入3.28亿元，同比增长131.09%，实现净利润 1.04亿元，同比增长270.28%，基本每股收益为1.5648元，加权平均净资产收益率4.21%。 7月11日公司发布上半年业绩预告，预计实现净利润2.20亿元至2.80亿元，同比变动区间为 123.09%~183.93%。（数据宝） 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） 博隆技术股价创出历史新高，截至9:32，该股上涨3.17%，股价报102.01元，成交量47.51万股，成交金 额4833.12万元，换手率1.67%，该股最新A股总市值达68.01亿元，该股A股流通市值29.06亿元。 证券时报·数据宝统计显示，博隆技术所属的机械设备行业，目前整体涨幅为0.41%，行业内，目前股价 上涨的有343只，涨幅居前的有德固特、三川智慧、长荣股份等，涨幅分别为19.98% ...

Group 1 - The company held its second board meeting on July 10, 2025, with all 8 directors present, complying with legal and regulatory requirements [2][3][4] - The board approved the appointment of Mr. Chen Haijian as the Chief Financial Officer, effective immediately until the end of the current board's term [3][4][6] Group 2 - The company forecasts a net profit attributable to shareholders for the first half of 2025 to be between 220 million to 280 million yuan, representing an increase of 121.09 million to 181.38 million yuan compared to the same period last year, which is a year-on-year increase of 123.09% to 183.93% [8][9] - The expected net profit after deducting non-recurring gains and losses is projected to be between 211 million to 271 million yuan, with an increase of 135.74 million to 195.75 million yuan year-on-year, translating to a growth of 180.38% to 260.11% [9][10] - The increase in profit is attributed to the successful completion and acceptance of large projects and orders during the reporting period [10]

Group 1 - Seli Medical's therapeutic hypertension vaccine project faces significant uncertainty despite recent market interest, with a 2024 revenue of 26,800 yuan and a net loss of 2,382,300 yuan [3] - Renfu Pharmaceutical's shareholder plans to increase their stake with a loan commitment of up to 750 million yuan, aiming to acquire 1% to 2% of the company's shares at a maximum price of 25.53 yuan per share [4] - China Northern Rare Earth's third-quarter trading price for rare earth concentrate is set at 19,109 yuan per ton, with price adjustments based on REO percentage changes [7][9] Group 2 - Saisir expects a net profit increase of 66.2% to 96.98% for the first half of 2025, driven by new product launches and improved sales [13] - WuXi AppTec anticipates a 44.43% increase in adjusted net profit for the first half of 2025, with revenue expected to reach approximately 20.799 billion yuan [15] - Yiyuan Communication forecasts a 121.13% increase in net profit for the first half of 2025, capitalizing on the growth of 5G and AI technologies [16] Group 3 - Longqing Co. expects a net profit increase of 106.02% to 131.77% for the first half of 2025, attributed to production capacity release and cost reduction [17] - Guosheng Financial Holdings predicts a net profit increase of 236.85% to 394.05% for the first half of 2025, supported by improved brokerage and investment banking performance [18] - Dali Long anticipates a net profit increase of 162.38% to 249.84% for the first half of 2025, driven by market expansion and operational efficiency [19] Group 4 - Tianbao Infrastructure expects a staggering net profit increase of 1581.8% to 2329.27% for the first half of 2025, largely due to a significant tax refund [20] - China Shipbuilding anticipates a net profit increase of 98.25% to 119.49% for the first half of 2025, benefiting from improved production efficiency and order structure [21] - Shanghai Xiba expects a net profit increase of 136.47% to 181.85% for the first half of 2025, influenced by non-recurring income [22] Group 5 - *ST Yanzhen reports a total of 53.773 million shares accepted in a tender offer, representing 20.47% of total equity, with a new major shareholder emerging [12] - Shanghai Mechanical and Electrical's major shareholder has received approval for a share transfer that will not change the company's control [10] - Good Products plans to suspend trading due to a potential change in control, with a suspension expected for no more than two trading days [11]

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen markets have released important announcements, highlighting significant developments and performance forecasts that may impact investor decisions [1]. Company Announcements - **Saili Medical**: The therapeutic hypertension vaccine project by its affiliate, Huajiyuan Biotechnology, faces significant uncertainty despite recent market interest in innovative drugs. The company holds a 15.61% stake in Huajiyuan, which reported a revenue of 26,800 yuan and a net loss of 2,382,300 yuan for 2024 [3]. - **Renfu Pharmaceutical**: Shareholder,招商生科, has secured a loan commitment of up to 750 million yuan from招商银行武汉分行 to increase its stake in Renfu Pharmaceutical. The planned share buyback will occur within six months starting from July 3, 2025, with a maximum purchase price of 25.53 yuan per share [4]. - **China Merchants Energy Shipping**: The company has received a new multi-purpose heavy-lift vessel, "Mingshi," as part of its order for four eco-friendly vessels. The fleet now includes 102 operational bulk carriers, with 16 vessels on order for future delivery [5]. - **Shangwei New Materials**: The company announced a significant stock price fluctuation, with a 30% increase over two days. A share transfer agreement was signed, potentially changing the controlling shareholder to Zhiyuan Hengyue, pending shareholder approval [6]. - **Northern Rare Earth**: The trading price for rare earth concentrates has been adjusted to 19,109 yuan per ton for Q3 2025, based on market conditions [7]. - **Baotou Steel**: Similar to Northern Rare Earth, Baotou Steel has proposed an adjustment of the rare earth concentrate trading price to 19,109 yuan per ton for Q3 2025 [9]. - **Shanghai Mechanical & Electrical**: The company received approval from the Shanghai State-owned Assets Supervision and Administration Commission for the transfer of 51.137 million shares from its controlling shareholder, Shanghai Electric, without changing control [10]. Performance Forecasts - **Eyer Communication**: The company expects a net profit of approximately 463 million yuan for the first half of 2025, a year-on-year increase of about 121.13%, driven by growth in the IoT sector [12]. - **Tianbao Infrastructure**: The company forecasts a net profit of 90 million to 130 million yuan for the first half of 2025, representing a year-on-year increase of 1581.8% to 2329.27% due to tax recoveries [13]. - **China Shipbuilding**: The expected net profit for the first half of 2025 is between 2.8 billion and 3.1 billion yuan, reflecting a year-on-year increase of 98.25% to 119.49% due to improved production efficiency and order structure [14]. - **Shanghai Xiba**: The company anticipates a net profit of 99 million to 118 million yuan for the first half of 2025, a year-on-year increase of 136.47% to 181.85%, primarily due to non-recurring income [15]. - **Longyuan Technology**: The expected net profit for the first half of 2025 is between 26 million and 31 million yuan, reflecting a year-on-year increase of 116.61% to 158.26% [16]. - **Zhengbang Technology**: The company forecasts a net profit of 190 million to 210 million yuan for the first half of 2025, marking a return to profitability driven by increased pig sales [17][18]. - **Bolong Technology**: The expected net profit for the first half of 2025 is between 22 million and 28 million yuan, a year-on-year increase of 123.09% to 183.93% due to successful project deliveries [19]. - **Haitou Shares**: The company anticipates a net profit of approximately 380 million yuan for the first half of 2025, a year-on-year increase of about 233.10% due to favorable market conditions [20]. - **Chuangjiang New Materials**: The expected net profit for the first half of 2025 is between 24 million and 29 million yuan, reflecting a year-on-year increase of 42.35% to 72% [21]. - **Hudian Shares**: The company forecasts a net profit of between 1.65 billion and 1.75 billion yuan for the first half of 2025, a year-on-year increase of 44.63% to 53.4% [22]. - **Taiping Bird**: The company expects a net profit of around 77.7 million yuan for the first half of 2025, a decrease of approximately 55% due to declining retail performance [23]. - **China Satellite**: The company anticipates a loss of between 21.2 million and 41.2 million yuan for the first half of 2025, attributed to reduced contract fulfillment and increased operational costs [24]. - **ST Yatai**: The company expects a loss of between 12.6 million and 20.9 million yuan for the first half of 2025, primarily due to cash flow issues and increased non-recurring expenses [25]. Major Contracts - **Bai Da Group**: The company signed a significant leasing contract for the Hangzhou Department Store, with a rental agreement of 375 million yuan per quarter, increasing by 4.5% every three years [26]. Shareholding Changes - **Baoshui Technology**: A major shareholder plans to reduce their stake by up to 1% through market transactions between August 4 and November 3, 2025 [28].

Group 1 - The company expects to achieve a net profit attributable to shareholders of the parent company for the first half of 2025 in the range of 220 million to 280 million yuan, representing an increase of 121.39 million to 181.39 million yuan compared to the same period last year, which corresponds to a year-on-year increase of 123.09% to 183.93% [1][2] - The net profit attributable to shareholders of the parent company, excluding non-recurring gains and losses, is also projected for the first half of 2025 [2] - The significant increase in net profit is attributed to the successful completion and acceptance of large projects and orders during the reporting period, with the amount of projects delivered and accepted in the first half of 2025 showing a substantial increase compared to the same period last year [2] Group 2 - The company's total profit for the same period last year was 111.48 million yuan, with a net profit attributable to shareholders of the parent company of 98.62 million yuan, and a net profit excluding non-recurring gains and losses of 75.25 million yuan [2] - The earnings per share for the same period last year was 1.5435 yuan [2] - The company emphasizes that the performance forecast is based on preliminary calculations by the finance department and has not yet been audited by an accounting firm [2]

证券代码：603325 证券简称：博隆技术 公告编号：2025-017 上海博隆装备技术股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 三、备查文件 （一）第二届董事会第八次会议决议 （二）第二届董事会提名委员会第二次会议决议 行政法规、部门规章、规范性文件及《公司章程》的有关规定。 二、董事会会议审议情况 （一）审议通过《关于聘任公司财务总监的议案》 为保证公司财务管理工作的有序开展，根据《公司法》及《公司章程》的有 关规定，经总经理张玲珑先生提名，董事会提名委员会资格审查、董事会审计委 员会审议通过，同意聘任陈海建先生（简历见附件）为公司财务总监，任期自本 次董事会审议通过之日起至第二届董事会任期届满之日止。 表决结果：8 票同意、0 票反对、0 票弃权。 一、董事会会议召开情况 上海博隆装备技术股份有限公司（以下简称公司）第二届董事会第八次会议 于 2025 年 7 月 10 日在公司会议室以现场结合通讯表决方式召开，会议通知及材 料于 2025 年 7 月 7 日以电子邮件方式发给全体董事。本次会议由公司 ...

证券代码：603325 证券简称：博隆技术 公告编号：2025-017 上海博隆装备技术股份有限公司（以下简称公司）第二届董事会第八次会议 于 2025 年 7 月 10 日在公司会议室以现场结合通讯表决方式召开，会议通知及材 料于 2025 年 7 月 7 日以电子邮件方式发给全体董事。本次会议由公司董事长张玲 珑先生召集并主持，应出席董事 8 名，实际出席董事 8 名（其中以通讯表决方式 出席会议董事 4 名）。公司监事、高级管理人员、财务总监候选人列席会议。本次 会议的召集和召开符合《中华人民共和国公司法》（以下简称《公司法》）等法律、 行政法规、部门规章、规范性文件及《公司章程》的有关规定。 二、董事会会议审议情况 （一）审议通过《关于聘任公司财务总监的议案》 为保证公司财务管理工作的有序开展，根据《公司法》及《公司章程》的有 关规定，经总经理张玲珑先生提名，董事会提名委员会资格审查、董事会审计委 员会审议通过，同意聘任陈海建先生（简历见附件）为公司财务总监，任期自本 次董事会审议通过之日起至第二届董事会任期届满之日止。 上海博隆装备技术股份有限公司 第二届董事会第八次会议决议公告 本公司董事会及全体 ...